Concepedia

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

Jennifer Hammond, Robert J. Fountaine, Carla Yunis, Dona Fleishaker, Mary Almas, Weihang Bao, Wayne Wisemandle, Mary Lynn Baniecki, Victoria M. Hendrick, Veselin Kalfov,

New England Journal of Medicine · 2024 · 118 citations · 11 references

DOIFull text

Open access

Abstract

The time to sustained alleviation of all signs and symptoms of Covid-19 did not differ significantly between participants who received nirmatrelvir-ritonavir and those who received placebo. (Supported by Pfizer; EPIC-SR ClinicalTrials.gov number, NCT05011513.).

References

11

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

Zunyou Wu, Jennifer M. McGoogan · JAMA · 2020 · 17.8K citations · Full text

, , +16

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Annemarie B Docherty, Ewen M. Harrison, Christopher Green et al. · BMJ · 2020 · 3.6K citations · Full text

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

New England Journal of Medicine · 2022 · 2.1K citations · Full text

An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.8K citations · Full text

, , +16

Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)

Lindsay Kim, Shikha Garg, Alissa O’Halloran et al. · Clinical Infectious Diseases · 2020 · 667 citations · Full text